Literature DB >> 1934594

Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

M G Cavallo1, P Pozzilli, C Bird, M Wadhwa, A Meager, N Visalli, A J Gearing, D Andreani, R Thorpe.   

Abstract

Cytokines are known to play an important role in autoimmunity and have been suggested to be involved in the pathogenesis of insulin-dependent diabetes (IDDM). In the present study we have measured IL-1, IL-2, IL-4, IL-6, interferon-gamma (IFN-gamma) and tumour necrosis factor (TNF) (using both immunoassays and bioassays) in sera from 50 patients affected by IDDM at the time of clinical diagnosis and 51 age and sex matched controls. Detectable levels of IL-1, IL-2, IL-6 and IFN-gamma were found in the serum of a small percentage of subjects and were not significantly different between patients and controls. IL-4 was detectable in a higher number of both patients and controls and circulating TNF-alpha (greater than 1 U/ml) was found in a percentage of patients (24%) significantly higher than controls (P less than 0.01). Raised levels of TNF-alpha were detectable using an immunoenzymatic assay whereas TNF bioactivity in these samples was negligible. We conclude that the presence of immunoreactive TNF-alpha in the patient's sera may reflect an increased localized production of this cytokine at pancreatic level. However, the measurement in serum of other cytokines does not add information on the role that they may play in the pathogenesis of IDDM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934594      PMCID: PMC1554128          DOI: 10.1111/j.1365-2249.1991.tb05806.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

Review 2.  Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus.

Authors:  T Mandrup-Poulsen; S Helqvist; J Mølvig; L D Wogensen; J Nerup
Journal:  Autoimmunity       Date:  1989       Impact factor: 2.815

3.  A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2.

Authors:  A J Gearing; C R Bird; A Bristow; S Poole; R Thorpe
Journal:  J Immunol Methods       Date:  1987-05-04       Impact factor: 2.303

4.  Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; J Egeberg; J H Nielsen
Journal:  Allergy       Date:  1986-05       Impact factor: 13.146

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Sensitive and specific immunoradiometric assays for human interleukin-1 alpha.

Authors:  R Thorpe; M Wadhwa; A Gearing; B Mahon; S Poole
Journal:  Lymphokine Res       Date:  1988

7.  Lymphocyte subsets and activation in prediabetes.

Authors:  C L Hitchcock; W J Riley; A Alamo; R Pyka; N K Maclaren
Journal:  Diabetes       Date:  1986-12       Impact factor: 9.461

8.  Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena.

Authors:  K C Herold; A Huen; L Gould; H Traisman; A H Rubenstein
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

9.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

10.  Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF).

Authors:  A Meager; S Parti; H Leung; E Peil; B Mahon
Journal:  Hybridoma       Date:  1987-06
View more
  24 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Role of cytokines in the pathogenesis of autoimmune diabetes mellitus.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.

Authors:  M J Hussain; M Peakman; H Gallati; S S Lo; M Hawa; G C Viberti; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.

Authors:  M Andrade Lima Gabbay; M N Sato; A J S Duarte; S A Dib
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

6.  Glucose intolerance modifies the inflammatory response after intestinal ischemia-reperfusion.

Authors:  Juan C Garcia-Perez; Javier Arias-Diaz; Elena Vara; Jose L Balibrea
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

7.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

8.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  High serum levels of soluble CD8 in insulin-dependent diabetes.

Authors:  E Di Cesare; M Previti; M C Ingemi; G F Bagnato; D Cucinotta
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats.

Authors:  Sushil K Jain; Justin L Rains; Jennifer L Croad
Journal:  Free Radic Biol Med       Date:  2007-05-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.